Histological and Immunohistochemical Evaluation of Ductal Carcinoma In Situ Co-Existing with Triple-Negative Carcinoma of the Breast

被引:0
作者
Seol, Hyesil [1 ]
Ko, Hyoungsuk [1 ]
Park, In Ae [1 ]
机构
[1] Seoul Natl Univ Hosp, Dept Pathol, Seoul 110744, South Korea
关键词
Breast; Noninfiltrating intraductal carcinoma; Immunohistochemistry;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background : Triple-negative breast carcinomas (TNBCs) are associated with high-grade histological tumor and a poor clinical outcome. In this study, we evaluated the histology and immunohistochemical features of DCIS co-existing with TNBC to determine the characteristics of the precursor lesions of TNBC. Methods: Among the 1,610 cases of breast carcinoma, we selected the TINBCs with DCIS (n=196), and compared the pathological and immunohistochemical findings of the DCIS with those of the invasive carcinoma areas. Results : Among the 1,610 breast carcinomas, the TNBCs accounted for 330 cases (20.5%) and there were 196 cases with DCIS. The TN-DCIS cases exhibited high nuclear (94.5%) and histological (94.5%) grades, comedo-necrosis (68.9%) and a small extent of the DCIS-involved area. Immunohistochemically, a p53 expression was present in 48.4% of the TN-DCIS cases and a high Ki-67 index was present in 31.5%. The same TN immunohistochemical profiles as the carcinoma were detected in 109 of the 124 (87.9%) cases, but different profiles were observed in 15 of the 124 (12.1%) cases. The 15 discordant cases were associated with a low histological grade (p=0.037), low p53-positivity (p=0.006) and a low Ki-67 index (p=0.026), as compared to the invasive carcinomas. Conclusions : The results of this study suggest that TN DICIS is a highly probable, but not obligate, precursor lesion of TNBC.
引用
收藏
页码:373 / 380
页数:8
相关论文
共 25 条
[1]   High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses [J].
Abd El-Rehim, DM ;
Ball, G ;
Pinder, SE ;
Rakha, E ;
Paish, C ;
Robertson, JFR ;
Macmillan, D ;
Blamey, RW ;
Ellis, IO .
INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (03) :340-350
[2]   Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution [J].
Allred, D. Craig ;
Wu, Yun ;
Mao, Sufeng ;
Nagtegaal, Iris D. ;
Lee, Sangjun ;
Perou, Charles M. ;
Mohsin, Syed K. ;
O'Connell, Peter ;
Tsimelzon, Anna ;
Medina, Dan .
CLINICAL CANCER RESEARCH, 2008, 14 (02) :370-378
[3]   Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers [J].
Bertucci, Francois ;
Finetti, Pascal ;
Cervera, Nathalie ;
Charafe-Jauffret, Emmanuelle ;
Mamessier, Emilie ;
Adelaide, Jose ;
Debono, Stephane ;
Houvenaeghel, Gilles ;
Maraninchi, Dominique ;
Viens, Patrice ;
Charpin, Colette ;
Jacquemier, Jocelyne ;
Birnbaum, Daniel .
CANCER RESEARCH, 2006, 66 (09) :4636-4644
[4]   Ductal carcinoma in situ with basal-like phenotype:: a possible precursor to invasive basal-like breast cancer [J].
Bryan, BB ;
Schnitt, SJ ;
Collins, LC .
MODERN PATHOLOGY, 2006, 19 (05) :617-621
[5]   Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study [J].
Carey, Lisa A. ;
Perou, Charles M. ;
Livasy, Chad A. ;
Dressler, Lynn G. ;
Cowan, David ;
Conway, Kathleen ;
Karaca, Gamze ;
Troester, Melissa A. ;
Tse, Chiu Kit ;
Edmiston, Sharon ;
Deming, Sandra L. ;
Geradts, Joseph ;
Cheang, Maggie C. U. ;
Nielsen, Torsten O. ;
Moorman, Patricia G. ;
Earp, H. Shelton ;
Millikan, Robert C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21) :2492-2502
[6]   Basal-like breast cancer defined by five biomarkers has superior prognostic value then triple-negative phenotype [J].
Cheang, Maggie C. U. ;
Voduc, David ;
Bajdik, Chris ;
Leung, Samuel ;
McKinney, Steven ;
Chia, Stephen K. ;
Perou, Charles M. ;
Nielsen, Torsten O. .
CLINICAL CANCER RESEARCH, 2008, 14 (05) :1368-1376
[7]   Triple-negative breast cancer: therapeutic options [J].
Cleator, Susan ;
Heller, Wolfgang ;
Coombes, R. Charles .
LANCET ONCOLOGY, 2007, 8 (03) :235-244
[8]   Basal phenotype of ductal carcinoma in situ:: recognition and immunohistologic profile [J].
Dabbs, David J. ;
Chivukula, Mamatha ;
Carter, Gloria ;
Bhargava, Rohit .
MODERN PATHOLOGY, 2006, 19 (11) :1506-1511
[9]   Expression of luminal and basal cytokeratins in human breast carcinoma [J].
El-Rehim, DMA ;
Pinder, SE ;
Paish, CE ;
Bell, J ;
Blamey, R ;
Robertson, JFR ;
Nicholson, RI ;
Ellis, IO .
JOURNAL OF PATHOLOGY, 2004, 203 (02) :661-671
[10]   Specificity of HercepTest in determining HER-2/neu status of breast cancers using the united states food and drug administration-approved scoring system [J].
Jacobs, TW ;
Gown, AM ;
Yaziji, H ;
Barnes, MJ ;
Schnitt, SJ .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :1983-1987